长链非编码RNA LncHDAC2通过激活Hedgehog信号通路驱动肝癌干细胞自我更新
本研究从3例原发性肝细胞癌(HCC)肿瘤组织中分选CD13+CD133+肝癌干细胞与CD13-CD133-非干细胞,用转录组芯片等方法发现lncHDAC2在HCC肿瘤及肝癌干细胞中高表达,通过招募NuRD复合物抑制PTCH1启动子激活Hedgehog信号,促进干细胞自我更新与肿瘤生长。
要点
- lncHDAC2在HCC肿瘤和肝癌干细胞中高表达,促进肝癌干细胞自我更新与肿瘤 propagation。
- lncHDAC2将NuRD复合物招募至PTCH1启动子抑制其表达,从而激活Hedgehog信号通路。
- HDAC2表达水平与HCC严重程度正相关,PTCH1水平与HCC严重程度负相关;Smo抑制剂环巴胺可损害肝癌干细胞自我更新并抑制肿瘤 propagation。
核心结论
- lncHDAC2通过激活Hedgehog信号通路促进肝癌干细胞自我更新和肿瘤 propagation,下调lncHDAC2是HCC有前景的抗肿瘤策略。
研究设计与样本
- 从3例原发性HCC肿瘤组织中分选CD13+CD133+细胞(肝癌干细胞)与CD13-CD133-细胞(非干细胞),行转录组芯片分析。
- 采用northern blot、成球实验和异种移植肿瘤模型评估lncHDAC2的表达与功能。
主要发现
- lncHDAC2在HCC肿瘤和肝癌干细胞中高表达,促进肝癌干细胞自我更新及肿瘤 propagation。
- 在肝癌干细胞中,lncHDAC2将NuRD复合物招募至PTCH1启动子抑制其表达,导致Hedgehog信号通路激活。
- HDAC2表达水平与HCC严重程度正相关,PTCH1水平与HCC严重程度负相关。
- Smo抑制剂环巴胺可损害肝癌干细胞自我更新并抑制肿瘤 propagation。
临床怎么用
- 作者认为lncHDAC2与Hedgehog信号通路可作为HCC的生物标志物和潜在药物靶点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Liver cancer is the second leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in adults. The aim of this study was to define the role of the long non-coding RNA lncHDAC2 in the tumorigenesis of HCC. METHODS: CD13+CD133+ cells (hereafter called liver cancer stem cells [CSCs]) and CD13-CD133- cells (referred to as non-CSCs) were sorted from 3 primary HCC tumor tissues and followed by transcriptome microarray. The expression and function of lncHDAC2 were further assessed by northern blot, sphere formation and xenograft tumor models. RESULTS: LncHDAC2 is highly expressed in HCC tumors and liver CSCs. LncHDAC2 promotes the self-renewal of liver CSCs and tumor propagation. In liver CSCs, lncHDAC2 recruits the NuRD complex onto the promoter of PTCH1 to inhibit its expression, leading to activation of Hedgehog signaling. Moreover, HDAC2 expression levels are positively related to HCC severity and PTCH1 levels are negatively related to HCC severity. Additionally, the Smo inhibitor cyclopamine was shown to impair the self-renewal of liver CSCs and suppress tumor propagation. CONCLUSION: Our findings reveal that lncHDAC2 promotes the self-renewal of liver CSCs and tumor propagation by activating the Hedgehog signaling pathway. Downregulating lncHDAC2 is a promising antitumor strategy in HCC. LAY SUMMARY: Liver cancer stem cells harbor high tumor-initiating potential and confer resistance to typical therapies, but the mechanism underlying their self-renewal remains elusive. LncHDAC2 augments the self-renewal of these cells, promoting tumor propagation. In liver cancer stem cells, lncHDAC2 activates Hedgehog signaling to initiate liver tumorigenesis. Therefore, lncHDAC2 and the Hedgehog signaling pathway may serve as biomarkers and potential drug targets for hepatocellular carcinoma.
引用
- Wu J, Zhu P, Lu T, et al. The long non-coding RNA LncHDAC2 drives the self-renewal of liver cancer stem cells via activation of Hedgehog signaling. J Hepatol. 2018. PMID: 30582981. doi:10.1016/j.jhep.2018.12.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。